ABT vs GAP · P/E 25, rev $44.33B vs P/E 9.9, rev $15.09B
Abbott Laboratories (ABT) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the ABT and GAP stock pages for the full models.
Not investment advice.